These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6369026)

  • 1. Mechanisms of elevated blood pressure in human essential hypertension.
    Davidman M; Opsahl J
    Med Clin North Am; 1984 Mar; 68(2):301-20. PubMed ID: 6369026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of altered renal sodium handling in age-related hypertension.
    Frame AA; Wainford RD
    Am J Physiol Renal Physiol; 2018 Jul; 315(1):F1-F6. PubMed ID: 29442548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Mechanisms of Sodium-Sensitive Hypertension in the Metabolic Syndrome.
    Nizar JM; Bhalla V
    Curr Hypertens Rep; 2017 Aug; 19(8):60. PubMed ID: 28676941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-modulating essential hypertension].
    Mohara O; Masuyama Y
    Nihon Rinsho; 1992 May; 50 Suppl():512-6. PubMed ID: 1512989
    [No Abstract]   [Full Text] [Related]  

  • 5. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system.
    Li P
    J Appl Physiol (1985); 2010 Dec; 109(6):2008. PubMed ID: 21188819
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension: perspectives.
    Beyer KH; Peuler JD
    Pharmacol Rev; 1982 Dec; 34(4):287-313. PubMed ID: 6763701
    [No Abstract]   [Full Text] [Related]  

  • 7. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Carotid stimulation studies support a prominent role for the sympathetic nervous system.
    Wehrwein EA
    J Appl Physiol (1985); 2010 Dec; 109(6):2009. PubMed ID: 21188821
    [No Abstract]   [Full Text] [Related]  

  • 8. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic nervous system, plasma volume, and hypertension.
    Christensen NJ
    J Appl Physiol (1985); 2010 Dec; 109(6):2003. PubMed ID: 21188813
    [No Abstract]   [Full Text] [Related]  

  • 9. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Sympathetic activation: cause or consequence of hypertension?
    Campos RR; Bergamaschi CT
    J Appl Physiol (1985); 2010 Dec; 109(6):2013-4. PubMed ID: 21188830
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 11. [Mechanisms of regulation of arterial blood pressure: role of the sympathetic nervous system and of the renin-angiotensin system in patients on a low-sodium diet].
    Lembo G; Autiero C; Morganti A; Ricci A; Volpe M; Condorelli M
    Minerva Med; 1987 Dec; 78(23):1745-52. PubMed ID: 2827060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Systemic hypertension--a "ratologist" point of view.
    Julien C
    J Appl Physiol (1985); 2010 Dec; 109(6):2004. PubMed ID: 21188799
    [No Abstract]   [Full Text] [Related]  

  • 13. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Obesity: a common prime mover of chronic activation of the sympathetic nervous system and the renin-angiotensin system in systemic hypertension?
    Szelényi Z
    J Appl Physiol (1985); 2010 Dec; 109(6):2008-9. PubMed ID: 21188835
    [No Abstract]   [Full Text] [Related]  

  • 14. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Remodeling of central sympathetic circuits precedes the development of hypertension.
    Murphy MN
    J Appl Physiol (1985); 2010 Dec; 109(6):2011-2. PubMed ID: 21188827
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypertension in Chronic Kidney Disease.
    Hamrahian SM; Falkner B
    Adv Exp Med Biol; 2017; 956():307-325. PubMed ID: 27873228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium and potassium as nutritional factors in the genesis, treatment and prevention of hypertension.
    Haddy FJ
    Bull N Y Acad Med; 1985 Dec; 61(10):917-25. PubMed ID: 3002532
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of chronic NO synthase inhibition in rats on renin-angiotensin system and sympathetic nervous system.
    Zanchi A; Schaad NC; Osterheld MC; Grouzmann E; Nussberger J; Brunner HR; Waeber B
    Am J Physiol; 1995 Jun; 268(6 Pt 2):H2267-73. PubMed ID: 7541960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. The dominant mechanism depends on individual circumstance.
    Mathai ML
    J Appl Physiol (1985); 2010 Dec; 109(6):2011. PubMed ID: 21188826
    [No Abstract]   [Full Text] [Related]  

  • 19. Aberrant Rac1-mineralocorticoid receptor pathways in salt-sensitive hypertension.
    Kawarazaki W; Fujita T
    Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):929-36. PubMed ID: 24111570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Dominant contributors for systemic hypertension--who leads, who follows?
    Braga VA
    J Appl Physiol (1985); 2010 Dec; 109(6):2007-8. PubMed ID: 21188840
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.